As COVID-19 shows, older people are particularly vulnerable to infectious diseases. IMI’s VITAL project is studying vaccines and immunity in older adults, to figure out the best strategies to keep people healthier for longer.
Head of Innovative Medicines Initiatives argues that the project’s technologies, knowledge and networks came together in the crisis. The successor programme must sustain these achievements and build on them
Pierre Meulien, director of the Innovative Medicines Initiative wants to see pooling of international research efforts to help curb the spread of COVID-19 and develop treatments for the respiratory infection it causes
Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. Read IMI Executive Director Dr Pierre Meulien’s perspective on what is needed to tackle antimicrobial resistance.